TRAX (First Tracks Biotherapeutics) Total Assets: $441.89 Mil (As of Dec. 2024)


TRAX First Tracks Biotherapeutics Inc TRAX
12 GF Score
Price $36.24
! 3 Warning Signs
View Full Analysis

What is First Tracks Biotherapeutics Total Assets?

First Tracks Biotherapeutics TRAX +11.85% 12 Total Assets is $441.89 Mil as of Dec. 2024. GuruFocus rates TRAX with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

First Tracks Biotherapeutics's Total Assets for the quarter that ended in Dec. 2024 was $441.89 Mil.

During the past 12 months, First Tracks Biotherapeutics's average Total Assets Growth Rate was 6.20% per year.

Total Assets is connected with ROA %. First Tracks Biotherapeutics's annualized ROA % for the quarter that ended in Dec. 2024 was -36.95%. Total Assets is also linked to Revenue through Asset Turnover. First Tracks Biotherapeutics's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

First Tracks Biotherapeutics  (NAS:TRAX) Total Assets Explanation

Total Assets is connected with ROA %.

First Tracks Biotherapeutics's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %=Net Income (Q: Dec. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Dec. 2024 ))/ count )
=-163.705/( (444.109+441.891)/ 2 )
=-163.705/443
=-36.95 %

Note: The Net Income data used here is one times the annual (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

First Tracks Biotherapeutics's Asset Turnover for the quarter that ended in Dec. 2024 is

Asset Turnover
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Dec. 2024 ))/ count )
=0/( (444.109+441.891)/ 2 )
=0/443
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

First Tracks Biotherapeutics Total Assets Related Terms

First Tracks Biotherapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for First Tracks Biotherapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

First Tracks Biotherapeutics Total Assets Chart

First Tracks Biotherapeutics Annual Data
Trend Dec23 Dec24
Total Assets
444.11 441.89

First Tracks Biotherapeutics Semi-Annual Data
Dec23 Dec24
Total Assets 444.11 441.89
TRAX
12GF Score
First Tracks Biotherapeutics Inc TRAX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

First Tracks Biotherapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

First Tracks Biotherapeutics's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (A: Dec. 2024 )+Total Liabilities (A: Dec. 2024 )
=391.596+50.295
=441.89

First Tracks Biotherapeutics's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets=Total Equity (Q: Dec. 2024 )+Total Liabilities (Q: Dec. 2024 )
=391.596+50.295
=441.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $441.89 Mil mean?
First Tracks Biotherapeutics (TRAX) has a Total Assets of $441.89 Mil as of Dec. 2024. The total amount of assets as recorded on a company's balance sheet. View historical data on First Tracks Biotherapeutics and its competitors.
Is First Tracks Biotherapeutics' Total Assets too high?
First Tracks Biotherapeutics' current Total Assets is $441.89 Mil. Overall, First Tracks Biotherapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does First Tracks Biotherapeutics' Total Assets compare to ALT and RGNX?
First Tracks Biotherapeutics' Total Assets of $441.89 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on First Tracks Biotherapeutics and its competitors. First Tracks Biotherapeutics's current Total Assets is $441.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is First Tracks Biotherapeutics stock overvalued right now?
First Tracks Biotherapeutics (TRAX) has a current Total Assets of $441.89 Mil. The current Total Assets is $441.89 Mil. First Tracks Biotherapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For First Tracks Biotherapeutics (TRAX), the current Total Assets is $441.89 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

First Tracks Biotherapeutics Business Description

Other Exchanges B43:Germany
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
12GF Score

Get the complete analysis for TRAX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$36.24
Price